Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenxiao Jia
Observed name:
W. Jia
Institutions:
Shandong Tumor Hospital,
Shandong First Medical University
Observed institutions:
Xinjiang Medical University,
Shandong University,
Shandong Tumor Hospital,
Wuhan Union Hospital,
Shandong First Medical University,
Second Affiliated Hospital of Xinjiang Medical University,
Huazhong University of Science and Technology
show all 7
ORCID:
0000-0001-6482-4496
Observed ORCID:
0000-0001-6482-4496
OpenAlex ID:
A5014603317
The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
2019
·
Wenxiao Jia
, Qianqian Gao
, et al.
·
Cancer Biology and Medicine
·
207
PDF
An especially high rate of radiation pneumonitis observed in patients treated with thoracic radiotherapy and simultaneous osimertinib
2020
·
Wenxiao Jia
, Hongbo Guo
, et al.
·
Radiotherapy and Oncology
·
65
PDF
MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer.
2018
·
Jinjin Zhang
, Juchao Ren
, et al.
·
PubMed
·
37
The prognostic role of circulating CD8+ T cell proliferation in patients with untreated extensive stage small cell lung cancer
2019
·
Ning An
, Haoyi Wang
, et al.
·
Journal of Translational Medicine
·
36
PDF
Long noncoding RNA THAP9-AS1 is induced by Helicobacter pylori and promotes cell growth and migration of gastric cancer
2019
·
Wenxiao Jia
, Jiaqin Zhang
, et al.
·
OncoTargets and Therapy
·
36
PDF
Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study
2021
·
Xiaoyang Zhai
, Wanhu Li
, et al.
·
Radiation Oncology
·
30
PDF
Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy
2021
·
Wenxiao Jia
, Qianqian Gao
, et al.
·
Radiation Oncology
·
27
PDF
Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases
2024
·
Ji Li
, Menglin Bai
, et al.
·
Cancer Letters
·
22
Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
2020
·
Yang Liu
, Wenxiao Jia
, et al.
·
Frontiers in Oncology
·
20
PDF
Downregulation of lncRNA XR_429159.1 Linked to Brain Metastasis in Patients With Limited-Stage Small-Cell Lung Cancer
2021
·
Ji Li
, Wang Jing
, et al.
·
Frontiers in Oncology
·
18
PDF
Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
2021
·
Ji Li
, Wang Jing
, et al.
·
OncoTargets and Therapy
·
17
PDF
Case Report: Transformation From Cold to Hot Tumor in a Case of NSCLC Neoadjuvant Immunochemotherapy Pseudoprogression
2021
·
Wenxiao Jia
, Hui Zhu
, et al.
·
Frontiers in Immunology
·
16
PDF
Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study
2019
·
Ning An
, Haoyi Wang
, et al.
·
OncoTargets and Therapy
·
16
PDF
Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathway
2025
·
Wenxiao Jia
, Lin Ma
, et al.
·
Cancer Letters
·
14
Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients
2024
·
Hanjing Yin
, Wenxiao Jia
, et al.
·
BMC Cancer
·
10
PDF
High post‐chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy
2023
·
Wenxiao Jia
, Hongbo Guo
, et al.
·
MedComm
·
9
Synergistic enhancement of radio-immunotherapy efficacy by IL-15 via macrophage activation and memory T cell response
2025
·
Peng Jin
, Menglin Bai
, et al.
·
Cancer Letters
·
8
Comprehensive Analysis and Validation of Competing Endogenous RNA Network and Tumor-infiltrating Immune Cells in Lung Adenocarcinoma
2022
·
Hui Zhu
, Yang Liu
, et al.
·
Combinatorial Chemistry & High Throughput Screening
·
8
Severe Pulmonary Toxicity With Concurrent Anlotinib and Chemoradiotherapy in Stage III NSCLC: The ALTER-L042 Phase 1 Clinical Trial
2022
·
Hui Zhu
, Wenxiao Jia
, et al.
·
JTO Clinical and Research Reports
·
6
Role of Surgery in Potentially Resectable Small‐Cell Lung Cancer Based on the Eighth Edition of the TNM Classification: A Population Study of the US SEER Database
2024
·
Xiaokang Guo
, Bin Wang
, et al.
·
The Clinical Respiratory Journal
·
5
PDF
Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases
2023
·
Wenxiao Jia
, Xiaoyang Zhai
, et al.
·
Journal of Neuro-Oncology
·
4
Fatal Toxicity Induced by anti-PD-1 Immune Checkpoint Inhibitor in Thymic Epithelial Tumor
2022
·
Xuquan Jing
, Hui Zhu
, et al.
·
Immunotherapy
·
4
Osimertinib Greatly Increase the Risk of Radiotherapy Pneumonitis when Concurrent with Thoracic Radiotherapy
2020
·
W. Jia
, N. An
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
3
PDF
Multicenter Cohort Study of Original or Substitute Systemic Therapy With or Without Brain Radiotherapy for Extensive-Stage Small Cell Lung Cancer With Brain-Only Progression After First-Line Treatment
2026
·
Shuangqing Lu
, Jingyi Jia
, et al.
·
Journal of Clinical Oncology
·
2
Intratumoral microbiota: bidirectional modulation of tumor radiosensitivity
2026
·
Fangfei Zhu
, Shuting Han
, et al.
·
Frontiers in Immunology
PDF
Show more works
View as search
Works count:
31
Citation count:
620
H-index:
14
I10-index:
15
Year
Topic
Type